X-101391216-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_021029.6(RPL36A):c.3+170G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000602 in 624,199 control chromosomes in the GnomAD database, including 1 homozygotes. There are 99 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0021 ( 1 hom., 68 hem., cov: 23)
Exomes 𝑓: 0.00028 ( 0 hom. 31 hem. )
Consequence
RPL36A
NM_021029.6 intron
NM_021029.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.24
Genes affected
RPL36A (HGNC:10359): (ribosomal protein L36a) Cytoplasmic ribosomes, organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein, which shares sequence similarity with yeast ribosomal protein L44, belongs to the L44E (L36AE) family of ribosomal proteins. Although this gene has been referred to as ribosomal protein L44 (RPL44), its official name is ribosomal protein L36a (RPL36A). This gene and the human gene officially named ribosomal protein L36a-like (RPL36AL) encode nearly identical proteins; however, they are distinct genes. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. Naturally occurring read-through transcription occurs between this locus and the heterogeneous nuclear ribonucleoprotein H2 (H') gene. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant X-101391216-G-A is Benign according to our data. Variant chrX-101391216-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3031516.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Hemizygotes in GnomAd4 at 68 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RPL36A | NM_021029.6 | c.3+170G>A | intron_variant | ENST00000553110.8 | |||
RPL36A-HNRNPH2 | NM_001199973.2 | c.3+170G>A | intron_variant | ||||
RPL36A-HNRNPH2 | NM_001199974.2 | c.3+170G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RPL36A | ENST00000553110.8 | c.3+170G>A | intron_variant | 1 | NM_021029.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00206 AC: 231AN: 112382Hom.: 1 Cov.: 23 AF XY: 0.00197 AC XY: 68AN XY: 34534
GnomAD3 genomes
AF:
AC:
231
AN:
112382
Hom.:
Cov.:
23
AF XY:
AC XY:
68
AN XY:
34534
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000283 AC: 145AN: 511762Hom.: 0 Cov.: 8 AF XY: 0.000217 AC XY: 31AN XY: 143052
GnomAD4 exome
AF:
AC:
145
AN:
511762
Hom.:
Cov.:
8
AF XY:
AC XY:
31
AN XY:
143052
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00205 AC: 231AN: 112437Hom.: 1 Cov.: 23 AF XY: 0.00197 AC XY: 68AN XY: 34599
GnomAD4 genome
AF:
AC:
231
AN:
112437
Hom.:
Cov.:
23
AF XY:
AC XY:
68
AN XY:
34599
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
GLA-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 03, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at